{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:52:19Z","timestamp":1767837139886,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Current expert consensus recommends remote monitoring (RM) for cardiac implantable electronic devices (CIEDs). As this recommendation is primarily based on studies involving implantable cardioverter defibrillators (ICDs), the HERO (HEart Rhythm management Optimisation of pacemaker recipients using remote monitoring) study aimed to reinforce this recommendation for pacemaker recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The exploratory, retrospective, single-centre HERO study included 203 patients with an increased stroke risk (CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score \u2265\u202f2) but without a\u00a0history of atrial fibrillation or flutter, who received a\u00a0pacemaker between January 2016 and April 2018. Occurrence and detection time of atrial and ventricular arrhythmias were analysed in patients with RM (RM+; <jats:italic>n<\/jats:italic>\u202f=\u200960) and those without RM (RM\u2212; <jats:italic>n<\/jats:italic>\u202f=\u2009143), together with CIED adverse events, cardiology visits and anticoagulation adjustments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median age of the patients was 80\u00a0(73\u201385) years, with 55.2% being men. During a\u00a0median follow-up of 5.0\u00a0years, 53.7% were diagnosed with at least one arrhythmic event (RM+ 60.0% vs RM\u2212 51.0%, <jats:italic>p<\/jats:italic>\u202f=\u20090.28). The median time from pacemaker implantation to detection of first arrhythmic event was 2.5\u00a0(0.5\u20138.2) years in the RM+ group versus 2.8\u00a0(1.2\u20138.0) years in the RM\u2212 group (hazard ratio 0.89; 95% confidence interval 0.59\u20131.35; <jats:italic>p<\/jats:italic>\u202f=\u20090.58). There were no differences in the number of adverse events or anticoagulation adjustments during follow-up. More CIED telephone consultations were conducted in the RM+ group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A\u00a0substantial proportion of pacemaker patients experienced one or more arrhythmic events during follow-up. The HERO study did not demonstrate a\u00a0difference in time to detection of the first event when using remote monitoring.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12471-025-01953-4","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T13:00:05Z","timestamp":1746795605000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heart rhythm management optimisation of pacemaker recipients using remote monitoring: the HERO registry"],"prefix":"10.1007","volume":"33","author":[{"given":"Fleur W.","family":"Adriaansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim A. C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Voorhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Manfai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"Aagenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine J. M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Pisters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin E. W.","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"1953_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/europace\/eus440","volume":"15","author":"RP Ricci","year":"2013","unstructured":"Ricci\u00a0RP, Morichelli\u00a0L, D\u2019Onofrio\u00a0A, et\u00a0al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the homeguide registry. Europace. 2013;15:970\u20137.","journal-title":"Europace"},{"key":"1953_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr419","volume":"33","author":"P Mabo","year":"2012","unstructured":"Mabo\u00a0P, Victor\u00a0F, Bazin\u00a0P, et\u00a0al. A\u00a0randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart\u00a0J. 2012;33:1105\u201311.","journal-title":"Eur Heart J"},{"key":"1953_CR3","doi-asserted-by":"publisher","first-page":"e007734","DOI":"10.1161\/CIRCEP.119.007734","volume":"13","author":"E Watanabe","year":"2020","unstructured":"Watanabe\u00a0E, Yamazaki\u00a0F, Goto\u00a0T, et\u00a0al. Remote management of pacemaker patients with biennial in-clinic evaluation: continuous home monitoring in the Japanese at-home study: a\u00a0randomized clinical trial. Circ Arrhythm Electrophysiol. 2020;13:e7734.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1953_CR4","first-page":"92","volume":"2023","author":"AM Ferrick","year":"2023","unstructured":"Ferrick\u00a0AM, Raj\u00a0SR, Deneke\u00a0T, et\u00a0al. HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on practical management of the remote device clinic. Europace. 2023;2023:92\u2013144.","journal-title":"Europace"},{"key":"1953_CR5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/europace\/euac118","volume":"24","author":"G Boriani","year":"2022","unstructured":"Boriani\u00a0G, Burri\u00a0H, Svennberg\u00a0E, et\u00a0al. Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe. Europace. 2022;24:1875\u201380.","journal-title":"Europace"},{"key":"1953_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/joa3.12685","volume":"38","author":"V Russo","year":"2022","unstructured":"Russo\u00a0V, Rapacciuolo\u00a0A, Rago\u00a0A, et\u00a0al. Early evaluation of atrial high rate episodes using remote monitoring in pacemaker patients: results from the RAPID study. J\u00a0Arrhythm. 2022;38:213\u201320.","journal-title":"J Arrhythm"},{"key":"1953_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/pace.13062","volume":"40","author":"W Amara","year":"2017","unstructured":"Amara\u00a0W, Montagnier\u00a0C, Cheggour\u00a0S, et\u00a0al. Early detection and treatment of atrial arrhythmias alleviates the arrhythmic burden in paced patients: the SETAM study. Pacing Clin Electrophysiol. 2017;40:527\u201336.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1953_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G, Potpara\u00a0T, Dagres\u00a0N, et\u00a0al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J. 2021;42:373\u2013498.","journal-title":"Eur Heart J"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey\u00a0JS, Connolly\u00a0SJ, Gold\u00a0MR, et\u00a0al. Subclinical atrial fibrillation and the risk of stroke. N\u00a0Engl J Med. 2012;366:120\u20139.","journal-title":"N Engl J Med"},{"key":"1953_CR10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder\u00a0IC, Healey\u00a0JS, Crijns\u00a0H, et\u00a0al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart\u00a0J. 2017;38:1339\u201344.","journal-title":"Eur Heart J"},{"key":"1953_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey\u00a0JS, Lopes\u00a0RD, Granger\u00a0CB, et\u00a0al. Apixaban for stroke prevention in subclinical atrial fibrillation. N\u00a0Engl J Med. 2024;390:107\u201317.","journal-title":"N Engl J Med"},{"key":"1953_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","volume":"389","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof\u00a0P, Toennis\u00a0T, Goette\u00a0A, et\u00a0al. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N\u00a0Engl J Med. 2023;389:1167\u201379.","journal-title":"N Engl J Med"},{"key":"1953_CR13","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS). Eur Heart J.2024:3314\u2013414."},{"key":"1953_CR14","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.3390\/jcm12155066","volume":"12","author":"SA Bentounes","year":"2023","unstructured":"Bentounes\u00a0SA, Bisson\u00a0A, Fauchier\u00a0L. Atrial fibrillation associated with heart failure: perspectives from recent large clinical studies and translational research. J\u00a0Clin Med. 2023;12:5066.","journal-title":"J Clin Med"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-025-01953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-025-01953-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-025-01953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:17:51Z","timestamp":1747912671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-025-01953-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1007\/s12471-025-01953-4","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.E.W.\u00a0Hemels is an editor of the Netherlands Heart Journal and was the local principal investigator of the ARTESIA and NOAH-AFNET 6\u00a0trials. F.W.\u00a0Adriaansen, J.\u00a0Seelig, T.A.C.\u00a0de\u00a0Vries, L.\u00a0Voorhout, F.P.\u00a0Brouwers, B.\u00a0Manfai, R.\u00a0Derksen, C.\u00a0Aagenborg, C.J.M.\u00a0Doggen and R.\u00a0Pisters declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}